Renin-angiotensin system inhibitors and mortality in patients with COVID-19
Observational Study
[키워드] ACEi
acute respiratory syndrome
age
antihypertensive drugs
ARB
ARBs
Beta blockers
characterized
comorbid conditions
confounder
coronavirus
coronavirus disease
COVID-19
death
died
diuretics
drug
Emergency
evaluate
Follow-up
hypertension
Infection
inhibitor
inhibitors
IQR
laboratory-confirmed
large cohort
male
Mortality
no difference
outcome
Patient
patients with COVID-19
performed
RAS
recommendations
renin-angiotensin system
renin–angiotensin system
Renin–angiotensin system (RAS) inhibitors
retrospective
risk
risk of death
room
SARS-CoV-2
treated
Treatment
with COVID-19
[DOI] 10.1007/s15010-020-01550-0 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1007/s15010-020-01550-0 PMC 바로가기 [Article Type] Observational Study